Filing Details
- Accession Number:
- 0001267602-15-000072
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-11-16 16:15:36
- Reporting Period:
- 2015-04-30
- Filing Date:
- 2015-11-16
- Accepted Time:
- 2015-11-16 16:15:36
- Original Submission Date:
- 2015-05-04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1267602 | Alimera Sciences Inc | ALIM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1489533 | Daniel C. Myers | 6120 Windward Parkway, Suite 290 Alpharetta GA 30005 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-04-30 | 678 | $3.71 | 90,995 | No | 5 | A | Direct | |
Common Stock | Disposition | 2015-05-01 | 2,000 | $4.37 | 88,995 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- The Form 4 initially filed on May 4, 2015 inadvertently reported an incorrect number of shares acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan and thus the number of shares beneficially owned following the transaction was also incorrect.
- The Form 4 initially filed on May 4, 2015 inadvertently listed an incorrect price.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2014.